Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/16/2014 07/17/2014 07/18/2014 07/21/2014 07/22/2014 Date
40(c) 38.5(c) 39(c) 40(c) 40.44 Last
367 112 488 615 246 911 512 393 176 329 Volume
-3.90% -3.75% +1.30% +2.56% +1.10% Change
More quotes
Company
Proteome Sciences Plc is a protein biomarker discovery service company. It offers sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development. Its PS biomarker services uses isobaric and isotopic Tandem Mass Tag workflows developed on the... 
More about the company
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 4,78 M
EBIT 2014 -0,49 M
Net income 2014 0,28 M
Debt 2014 3,36 M
Yield 2014 -
Sales 2015 6,86 M
EBIT 2015 1,54 M
Net income 2015 1,89 M
Debt 2015 2,48 M
Yield 2015 -
PER 2014 400,00
PER 2015 44,44
EV / Sales 2014 18,6x
EV / Sales 2015 12,8x
Capitalization 85,6 M
More Financials
Latest news on PROTEOME SCIENCES PLC
6d ago PROTEOME SCIENCES : Significant step towards blood test for Alzheimer's
07/11 PROTEOME SCIENCES : to present Innovative Approaches & Novel Data for Alzheimer&..
07/09 PROTEOME SCIENCES : Notice of Director's Shareholding
07/08 PROTEOME SCIENCES : Non-Executive Buys Shares (DIRECTOR DEALINGS)
07/08 PROTEOME SCIENCES : Blood test for Alzheimer's moves considerably closer
07/08 PROTEOME SCIENCES : King's College London - Significant step towards blood test ..
07/08 PROTEOME SCIENCES : Publishes Study For Alzheimer's Blood Test
07/01 PROTEOME SCIENCES : Appointment of Roger McDowell as Non-Executive Director
06/02 THERMO FISHER SCIENTIFIC : Proteome Sciences Plc Announces Preliminary results
05/29 PROTEOME SCIENCES : Confident For Revenue Growth As Loss Narrows
04/08 PROTEOME SCIENCES : SysQuant® -Pancreatic Cancer Study Poster being presented at..
03/31 PROTEOME SCIENCES : SysQuant® -Pancreatic Cancer Study in PLOS ONE
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
Proteome Sciences plc : Income Statement Evolution
More Financials
EPS Revisions
Proteome Sciences plc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF